ONCIN Oncoinvent ASA
7.550USD73.00 NOK · OSL+2.53%Mkt Cap: 46.27M USDP/E: —1d ago
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. Oncoinvent ASA is based in Oslo, Norway.…